|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.51 / 1.65|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Asterias Biotherapeutics Inc , where a total of 852 contracts have traded so far, representing approximately 85,200 underlying shares. That amounts to about 41.9% of AST's average daily trading volume over the past month of 203,430 shares.
Industry News Supports Development of First-in-Class Allogeneic Cancer Immunotherapy
Data is Consistent with Early Data Read-Outs from Ongoing SCIStar Phase 1/2a Clinical Trial
Successful Production Run Provides Sufficient AST-VAC2 Supply to Initiate Clinical Study in Non-Small Cell Lung Cancer Expected to Begin in Second Half of 2017
Enrollment for entire SCiStar study expected to be completed by end-2017
New sites include Thomas Jefferson University Hospital and UC San Diego Health
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Asterias Biotherapeutics Inc , where a total volume of 767 contracts has been traded thus far today, a contract volume which is representative of approximately 76,700 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 47.8% of AST's average daily trading volume over the past month, of 160,485 shares.
BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the second quarter ended June 30, 2016 and provided a...
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Asterias...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.